Home Compliance DOJ Files Complaint in AWP False Claims Act Suit Against Pharmaceutical Ingredient... ComplianceExpert OpinionFCANews DOJ Files Complaint in AWP False Claims Act Suit Against Pharmaceutical Ingredient Seller November 18, 2021 20 Share FacebookLinkedinTwitter ShotPrime Studio | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance DOJ Plans to Apply the New Whistleblower Rewards Pilot Program to FCPA Cases Compliance Sixth Circuit Affirms Orders Compelling Relator to Seek Government Consent to Dismiss Qui Tam Pursuant to Settlement Agreement Compliance DOJ’s 90-Day Sprint Pilot Program Aims to Generate Information About Corporate Wrongdoing, But Numerous Questions Remain